The People-First Liver Charter

Affiliations

• ¹ City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. jeffrey.lazarus@sph.cuny.edu.
• ² Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. jeffrey.lazarus@sph.cuny.edu.
• ³ Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain. jeffrey.lazarus@sph.cuny.edu.
• ⁴ Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
• ⁵ Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, IL, USA.
• ⁶ Division of Molecular and Clinical Medicine, University of Dundee, Dundee, Scotland, UK.
• ⁷ Division of Endocrinology, Montefiore-Einstein Medical Center, New York, NY, USA.
• ⁸ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
• ⁹ Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
• ¹⁰ Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
• ¹¹ Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
• ¹² The Francis Crick Institute, London, UK.
• ¹³ Division of Infection and Immunity, University College London, London, UK.
• ¹⁴ Department of Infectious Diseases, University College London Hospital, London, UK.
• ¹⁵ City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.
• ¹⁶ The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
• ¹⁷ Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
• ¹⁸ School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• ¹⁹ Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
• ²⁰ Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
• ²¹ Department of Research and Innovation, APDP-Diabetes Portugal, Lisbon, Portugal.
• ²² Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, University Hospital, Düsseldorf, Germany.
• ²³ Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
• ²⁴ German Center for Diabetes Research (DZD), Partner Düsseldorf, Neuherberg, Germany.
• ²⁵ Fatty Liver Alliance, Toronto, Ontario, Canada.
• ²⁶ Dutch Liver Patients Association, Hoogland, the Netherlands.
• ²⁷ MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
• ²⁸ Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
• ²⁹ Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile.
• ³⁰ Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
• ³¹ Steatotic Liver Disease Program, Arizona Liver Health, Phoenix, AZ, USA.
• ³² Department of Internal Medicine II, Saarland University Medical Centre, Homburg, Germany.
• ³³ Faculty of Medicine, Saarland University, Saarbrücken, Germany.
• ³⁴ Department of Endocrinology & Nutrition, CIBERDEM, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• ³⁵ Faculty of Medicine, University of Vic-Central University of Catalonia, Vic, Spain.
• ³⁶ Division of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, IL, USA.
• ³⁷ Liver Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
• ³⁸ Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
• ³⁹ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEReHD), Barcelona, Spain.
• ⁴⁰ UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.
• ⁴¹ Hepatitis Education Project, Seattle, WA, USA.
• ⁴² World Hepatitis Alliance, London, UK.
• ⁴³ Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Florida, Gainesville, FL, USA.
• ⁴⁴ Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK.
• ⁴⁵ Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
• ⁴⁶ Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
• ⁴⁷ Metabolic Research Laboratory, CIBEROBN, ISCIII, IdiSNA, Clínica Universidad de Navarra, Pamplona, Spain.
• ⁴⁸ Department of Surgery, Bariatric Division, Department of Internal Medicine, NYU Grossman School of Medicine, New York, NY, USA.
• ⁴⁹ Division of Endocrinology, Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.
• ⁵⁰ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
• ⁵¹ VA Health Services Research and Development Service, Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX, USA.
• ⁵² Michael E DeBakey VA Medical Center, Houston, TX, USA.
• ⁵³ European Liver Patients' Association (ELPA), Brussels, Belgium.
• ⁵⁴ Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt.
• ⁵⁵ School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
• ⁵⁶ Department of Gastroenterology, Tel Aviv Medical Centre, Tel Aviv, Israel.
• ⁵⁷ Global Liver Institute, Washington, DC, USA.